Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases

NCT05139797 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.

NCT NCT05139797
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05139797 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases
Lead sponsor
Cedars-Sinai Medical Center
Phase
Observational
Overall status
Recruiting
Start date
November 18, 2021
Completion date
June 1, 2027
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac amyloidosis